42 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
. Performance conditions determine how many of these performance stock units will vest and, if performance targets are exceeded, additional performance … targets may occur may change. Such changes may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt reviews
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
units will vest and, if performance targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms … (i.e. regulatory requirements and the commercial success of the product), the timing of when such revenue targets may occur may change. Such changes
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
8:35am
targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms of the relevant performance stock units … to zero if before July 1, 2022
Revenue targets
US$35,000,000 upon Oleogel-S10 revenues exceeding US$75,000,000 in any 12-month period prior to June 30
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
7:45am
targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms of the relevant performance stock units … of the product), the timing of when such revenue targets may occur may change. Such changes may have a material impact on the assessment of the expected
6-K
EX-99.1
AMYT
Amryt Pharma Plc
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
period to March 31, 2022. Performance conditions determine how many of these performance stock units will vest and, if performance targets are exceeded … such revenue targets may occur may change. Such changes may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt
424B3
q3zgtttd
9 Mar 22
Prospectus supplement
9:26am
424B3
l6q63mb4xuy4s6g5h
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
q5gel54vdm302
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
424B3
uyymp2j69ivbynym8de
22 Nov 21
Prospectus supplement
7:39am
424B3
fbh6938c
22 Nov 21
Prospectus supplement
7:38am
6-K
EX-99.3
q3u3mnb3y
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
424B3
dwlmdu4
3 Nov 21
Prospectus supplement
7:33am
424B3
1mv5f vr32q2criw
3 Nov 21
Prospectus supplement
7:32am
6-K
EX-99.1
l43vhcqa5m 67
3 Nov 21
Amryt Reports Strong Q3 2021 Results
7:31am
6-K
EX-99.2
jhx4211inzmjf6qq
13 Sep 21
Current report (foreign)
8:48am
424B3
ownvnru9ibsqwgl9oq89
6 Aug 21
Prospectus supplement
8:18am
6-K
EX-99.1
rsc68k0c9z1qm
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am
424B3
v5sctn5g yhsu
6 Aug 21
Prospectus supplement
8:17am
424B3
1shq53vl0bl or
1 Jul 21
Prospectus supplement
5:20pm